|
|
Reference
|
|
 
|
*** (2008) Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation. Stroke, 39(6): 1901
|
|
|
Aboaf, A.P., Wolf, P.S. (1996) Paroxysmal atrial fibrillation. A common but neglected entity. Arch Intern Med, 156(4): 362-7
|
|
|
Fang, M.C., Go, A.S., Chang, Y., i dr. (2008) Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation. Journal of the American College of Cardiology, 51(8): 810
|
|
|
Fang, M.C., Go, A.S., Chang, Y., i dr. (2007) Death and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages. American Journal of Medicine, 120(8): 700
|
|
|
Friberg, L., Hammar, N., Ringh, M., i dr. (2006) Stroke prophylaxis in atrial fibrillation: who gets it and who does not?: Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). European Heart Journal, 27(16): 1954
|
|
|
Fuster, V., Rydén, L.E., Cannom, D.S., i dr. (2007) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology. European Heart Journal, 28(16): 2046
|
|
3
|
Gage, B.F., Waterman, A.D., Shannon, W., Boechler, M., Rich, M.W., Radford, M.J. (2001) Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA, 285(22): 2864-70
|
|
|
Go, A.S., Hylek, E.M., Chang, Y., Phillips, K.A., Henault, L.E., Capra, A.M., Jensvold, N.G., Selby, J.V., Singer, D.E. (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?. JAMA, 290(20): 2685-92
|
|
2
|
Hart, R.G., Pearce, L.A., Aguilar, M.I. (2007) Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 146(12): 857-67
|
|
|
Hart, R.G., Pearce, L.A., Rothbart, R.M., Mcanulty, J.H., Asinger, R.W., Halperin, J.L. (2000) Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol, 35(1): 183-7
|
|
1
|
Hohnloser, S.H., Pajitnev, D., Pogue, J., Healey, J.S., Pfeffer, M.A., Yusuf, S. (2007) Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet TherapyAn ACTIVE W Substudy. Journal of the American College of Cardiology, 50(22): 2156
|
|
|
Hughes, M., Lip, G.Y. (2008) Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost, 99(2): 295-304
|
|
|
Nieuwlaat, R., Dinh, T., Olsson, S.B., Camm, A.J., Capucci, A., Tieleman, R.G., i dr. (2008) Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?. European Heart Journal, 29(7): 915
|
|
1
|
Nieuwlaat, R., Capucci, A., Lip, G.Y., Olsson, S.B., Prins, M.H., Nieman, F.H., i dr. (2006) Antithrombotic treatment in real-life atrial fibrillation patients: A report from the euro heart survey on atrial fibrillation. Eur Heart J, 27(24), str. 3018-26
|
|
1
|
Odén, A., Fahlén, M., Hart, R.G. (2006) Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thrombosis Research, 117(5): 493
|
|
|
Rowan, S.B., Bailey, D.N., Bublitz, C.E., Anderson, R.J. (2007) Trends in anticoagulation for atrial fibrillation in the U.S.: An analysis of the national ambulatory medical care survey database. Journal of the American College of Cardiology, 49(14): 1561
|
|
|
Willems, R., Exner, D.V. (2004) Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials?. J Interv Card Electrophysiol, 10 Suppl 1: 9-16
|
|
5
|
Wolf, P.A., Abbott, R.D., Kannel, W.B. (1991) Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke, 22(8): 983-8
|
|
|
|
|